Sonya Sadani
About Sonya Sadani
Sonya Sadani is the Associate Director, Operations Portfolio Lead, I-O Head & Neck / Glioblastoma at Bristol Myers Squibb in New Jersey, with extensive experience in clinical trials and regulatory affairs.
Title
Sonya Sadani currently holds the position of Associate Director, Operations Portfolio Lead for I-O Head & Neck / Glioblastoma at Bristol Myers Squibb. She is based in New Jersey, United States.
Company
Sonya Sadani is presently employed at Bristol Myers Squibb. She heads the operations portfolio for immuno-oncology, specifically focusing on head & neck and glioblastoma.
Previous Work Experience
Sonya Sadani has accumulated over 20 years of experience in the pharmaceutical industry, having previously worked at PharmaNet, Roche, Schering-Plough, Genentech, Actavis, and Bristol Myers Squibb. Her roles have included Operations Lead, Senior Clinical Trial Manager, Senior Clinical Research Scientist, Clinical Research Associate, and Program Associate.
Education and Expertise
Sonya Sadani has an extensive educational background from institutions like Rutgers University, where she completed graduate coursework in Clinical Research & Regulatory Affairs. She also attended the Thunderbird School of Global Management, achieving an Executive Certificate in Global Marketing, and the University of Tennessee, Knoxville, where she earned a B.S. in Nutrition. She studied at Seoul International School and Shelton Studios, where she learned Acting Technique.
Clinical Trial Management
Sonya Sadani has extensive experience managing both interventional and non-interventional clinical trials. Her work spans across all phases of clinical trials, from pre-clinical through phase IV, in both global and domestic settings. She has expertise in multiple disease areas including oncology, cardiology, rheumatology, endocrinology, and neurology.
Regulatory and Market Access Expertise
Sonya Sadani is proficient in dealing with regulatory bodies such as the EMA, FDA, MHRA (UK), NMPA (China), IHS/NHA (India), and TGA (Australia). She is experienced in market access strategies and has managed loss of exclusivity issues effectively.
Skills and Technical Proficiency
Sonya Sadani possesses strong skills in cross-cultural communication, process enhancements, and risk evaluation. Her proficiency extends to conducting root cause analyses, developing corrective action plans, and adhering to ICH/GCP guidance. She has experience with both on-site and remote monitoring, as well as conflict resolution within clinical operations.